Vivozon’s Non-Opioid PainKiller Has Been Granted the FDA’s Fast Track Designation


Applied Clinical Trials

MMS Holdings Inc., a data-focused CRO, announced that the company has assisted Korea-based Vivozon Inc. in achieving a Fast Track Designation from the Food and Drug Administration for VVZ-149, a non-opioid painkiller.   Read the full release here.

Related Videos
Related Content
© 2024 MJH Life Sciences

All rights reserved.